Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLight Science Technologies Regulatory News (LST)

Share Price Information for Light Science Technologies (LST)

Share Price is delayed by 15 minutes
Get Live Data
1.80    0.00 (0.00%)
Bid:
1.70
Ask:
1.90
Spread: 0.20 (11.765%)
Market Cap: £17.71m
LST Live PriceLast checked at - London Stock Exchange

Intraday Light Science Technologies Share Chart

CEM Contract Win

7 May 2026 07:00

RNS Number : 3160D
Light Science Tech. Holdings PLC
07 May 2026
 

Light Science Technologies Holdings plc

("LSTH", "Light Science", the "Company" or the "Group")

 

CEM Contract Win

 

New healthcare client aligned with strategy targeting higher margin revenue opportunities

 

Light Science Technologies Holdings plc (AIM: LST), the innovative technology and manufacturing business providing real-world solutions targeting issues including global food security and fire safety, announces that its Contract Electronics Manufacturing division ("CEM"), UK Circuits and Electronics Solutions Limited ("UKC"), has secured a new client in the healthcare devices sector.

 

The customer is a UK-headquartered, international healthcare manufacturer specialising in the design, production and supply of medical devices and consumables used across acute and community care settings. Its core product portfolio supports infection prevention, clinical waste management and surgical procedures, addressing critical, high-volume needs across healthcare systems globally.

 

The business has an established international footprint and a strong reputation for quality, reliability and regulatory compliance, supplying mission-critical products that are embedded within everyday clinical practice across hospitals and care environments worldwide.

 

The first order is valued at c. £160,000, with total annual orders from the customer potentially worth up c.£650,000 per annum going forward, subject to the contract proceeding as expected.

 

The CEM division continues to supply products to a growing number of customers across an increasingly broad range of market sectors, targeting long-term contracts that enhance revenue visibility. The Group remains focused on higher-margin opportunities while reducing exposure to individual markets and customers.

 

Simon Deacon, CEO of LSTH, commented: "We are delighted to have secured another contract win this week, further demonstrating the momentum building within the Group. We remain highly focused on converting the Group's pipeline and establishing long-term partnerships as we continue to re-position the CEM division into key high-margin growth markets including defence, medical and healthcare."

 

 

For additional information please contact:

 

Light Science Technologies Holdings plc

Simon Deacon, Chief Executive Officer

Jim Snooks, Chief Financial Officer

Andrew Hempsall, Chief Operating Officer

 

www.lightsciencetechnologiesholdings.com

via Walbrook PR

 

Shore Capital (Nominated Adviser and Broker)

Stephane Auton / George Payne

 

+44 (0)20 7408 4050

Walbrook PR Ltd (Media & Investor Relations)

Nick Rome / Marcus Ulker

Tel: +44 (0)20 7933 8780 or lst@walbrookpr.com

 

Notes to Editors:

 

About Light Science Technologies Holdings plc (www.lightsciencetechnologiesholdings.com)

 

Light Science Technologies Holdings plc ("LSTH") operates through three divisions: Passive fire protection ("PFP"); AgTech ("AGT") and contract electronics manufacturing ("CEM"). The Company is involved in the design, manufacturing, and installation of products and customized solutions spanning various industry sectors, with a focus on addressing global challenges related to food security, climate change, and fire protection, the Group is committed to developing robust solutions in these rapidly growing market sectors.

 

As both an installer and supplier of the fire resistant graphite barrier system Injectaclad, the PFP division is strongly positioned to capture a growing proportion of the fire remediation market as the Buildings Safety Regulator ("BSR") backlog unblocks, enabling accelerated conversion of the Company's strong sales pipeline. The Injectaclad system is a solution for the retrospective installation of cavity fire barriers in buildings using a pumped system, thereby avoiding the need for full-scale façade removal. It addresses a significant problem in the UK's built environment, where thousands of buildings require remediation to meet fire safety standards. For more information please visit Cavity Fire Barrier Remediation System | Injectaclad Ltd

 

The Group's tailored AgTech solutions encompass control systems, grow lights, sensor technology, venting, and irrigation systems, catering to both UK and global customers. Key markets include indoor, vertical, glasshouses, polytunnels, and more recently wider applications in broadacre farming. Driving factors comprise global food and water shortages, a growing population, government policies promoting sustainable growth methods, heightened scrutiny of food production's impact on climate change, and a shift away from processed foods. Key markets span Eastern Europe, the Americas, Australasia, and select locations in the Middle East, with the Company expanding routes to market via low-cost, low risk distribution agreements globally. For more information please visit: Sustainable grow lights and sensor technology - Light Science Technologies

 

The CEM division excels in designing, procuring, and manufacturing high-quality electronic products, with a specialisation in Printed Circuit Boards. These products find application across diverse sectors such as audio, automotive, electronics, gas detection, lighting, pest control, telecommunications and AgTech. For more information please visit: Home | UK Circuits

 

The Group is strongly positioned across a range of high growth sectors with proven technologies and solutions. It is increasingly focused on high margin opportunities that will drive cash generation. Furthermore, it is positioned for accelerated growth, targeting larger contracts and increasing recurring revenues - as both legislation and global issues look set to underpin demand for its products, driving the Company towards sustained profitable growth.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTDQLFBQELXBBD
Date   Source Headline
22nd Jan 20241:24 pmRNSHolding(s) in Company
10th Jan 20247:00 amRNSTrading Update
21st Nov 20238:25 amRNSCorrection re: Acquisition of Injecta Fire Barrier
21st Nov 20237:00 amRNSAcquisition of Injecta Fire Barrier trade & assets
9th Nov 20239:21 amRNSHolding(s) in Company
12th Oct 202311:20 amRNSGrant of Options
10th Oct 20239:33 amRNSHolding(s) in Company
5th Oct 20237:00 amRNSExpansion of CEA Division’s Global Reach
21st Sep 20237:00 amRNSAward of Grant Funding
7th Sep 202310:51 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSInvestor Presentation
6th Sep 20237:00 amRNSAcquisition of Tomtech
31st Aug 20239:52 amRNSHolding(s) in Company
31st Aug 20237:00 amRNSHalf-year Report
17th Aug 20237:01 amRNSHolding(s) in Company
3rd Aug 20232:54 pmRNSHolding(s) in Company
28th Jul 20237:00 amRNSChange of Registered Office
29th Jun 20237:00 amRNSTrading Update
30th May 202312:26 pmRNSResult of AGM
9th May 20232:43 pmRNSHolding(s) in Company
5th May 20237:00 amRNSChange of Broker
3rd May 20237:00 amRNSFinal Results, Board Changes & Notice of AGM
27th Apr 20237:00 amRNSNotice of Results & Investor Presentation
26th Apr 20234:57 pmRNSHolding(s) in Company
25th Apr 20232:21 pmRNSHolding(s) in Company
24th Apr 20231:10 pmRNSHolding(s) in Company
21st Apr 20233:38 pmRNSResult of General Meeting & TVR
18th Apr 20237:00 amRNSResult of Fundraising and WRAP Retail Offer
6th Apr 202311:38 amRNSHolding(s) in Company
5th Apr 20234:42 pmRNSPosting of Circular
5th Apr 20234:00 pmRNSWRAP Retail Offer for up to £0.50 million
4th Apr 20237:00 amRNSProposed £1.50 million Placing and Subscription
1st Mar 202311:05 amRNSSecond Price Monitoring Extn
1st Mar 202311:00 amRNSPrice Monitoring Extension
1st Mar 20239:05 amRNSSecond Price Monitoring Extn
1st Mar 20239:00 amRNSPrice Monitoring Extension
27th Jan 20234:35 pmRNSPrice Monitoring Extension
27th Jan 20237:00 amRNSAppointment of Joint Broker
17th Jan 202311:05 amRNSSecond Price Monitoring Extn
17th Jan 202311:00 amRNSPrice Monitoring Extension
13th Jan 20239:05 amRNSSecond Price Monitoring Extn
13th Jan 20239:00 amRNSPrice Monitoring Extension
6th Dec 20228:01 amEQSLight Science Technologies looking ahead to 2023 after 'tough year'
5th Dec 202211:05 amRNSSecond Price Monitoring Extn
5th Dec 202211:00 amRNSPrice Monitoring Extension
2nd Dec 20227:00 amRNSTrading Update
1st Dec 20222:05 pmRNSSecond Price Monitoring Extn
1st Dec 20222:00 pmRNSPrice Monitoring Extension
24th Nov 202211:05 amRNSSecond Price Monitoring Extn
24th Nov 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.